The introduction of octyl-(R)-2-HG, a cell-permeable precursor of 2-HG, significantly reduces the half-maximum inhibitory concentration (IC50) of venetoclax in AML cells, with greater effects observed in cells expressing IDH1R132H mutation, compared to those with wild-type IDH1 [87]. The gene discussed is IDH1; the disease is acute myeloid leukemia.